Pancreatic surgical complications - The case for prophylaxis

Gut

Volumn 49, Issue SUPPL. 4, 2001, Pages

  Gouillat, C ^a   Gigot, J F ^b  

^a HÔTEL DIEU   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE;

ABSCESS; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EFFUSION; HUMAN; MORTALITY; PANCREAS DISEASE; PANCREAS FISTULA; PANCREAS SECRETION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PANCREATITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR;

CLINICAL TRIALS; GASTROINTESTINAL AGENTS; HUMANS; MULTICENTER STUDIES; OCTREOTIDE; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; SOMATOSTATIN;

EID: 0035185203     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery
2. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature
3. Duodenum-preserving pancreatic head resection: The future
4. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection
5. The complications of pancreatectomy
6. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: Drainage versus resection of the pancreatic remnant
7. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage
8. Complications of chronic pancreatitis
9. Carcinoma of the pancreas and periampullary region
10. Pancreatic cancer resection in elderly patients
11. Should pancreaticoduodenectomy be performed in octogenarians?
12. Effect of somatostatin 14 on pure human pancreatic secretion
13. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
14. Verhütung von postoperativen pankreatitischen komplikationen nach duodenopankreatektomie durch somastostatin
15. Somatostatin (two parts)
16. Inhibition of exocrine pancreatic secretion by somarostatin and its analogues
17. Pharmacokinetics of SMS 201-995 in healthy subjects
18. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man
19. Octreotide
20. All five cloned human somatostatin receptors (hSSTR 1-5) are functionally coupled to adenylate cyclase
21. Subtype selectivity of peptide analoges for all five cloned human somatostatin receptors (hsstr 1-5)
22. Molecular pharmacology of somatostatin-receptor subtypes
23. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors
24. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
25. Role of octreotide in the prevention of postoperative complications following pancreatic resection
26. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trial
27. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis
28. Intérêt de l'octréotide dans la prevention des complications chirurgicales post-opératoires après pancréatectomie - Étude prospective randomisée multicentrique
29. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease
30. A randomised controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy
31. Prevention of postoperative complications following pancreatic surgery
32. Inhibition of pancreatic secretion to prevent postoperative complications following pancreatic resection
33. The role of octreotide in the prevention of complications following pancreatic resection
34. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy
35. Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?
36. Profilaxis con somatostatina tras duodenopancreatectomía cefálica
37. The influence of somatostatin on postoperative outcome after elective pancreatic surgery
38. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: Implications for the management of fistulae